drug
as of 2026-07-01Dronabinol
MeSH D013759
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Dartmouth-Hitchcock Medical Center
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
4
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
NCT01964404Phase 1Completed
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
NCT01598896Phase 2, Phase 3Terminated
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
NCT00946348Phase 1Completed
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
NCT01832766Phase 1, Phase 2Terminated
KOLs & investigators
4
Alan I. Green, MDKOL score 5
Mary F. Brunette, MDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Alan I. Green, MD
personKOL score 5
Mary F. Brunette, MD
personKOL score 5
Kevin P Hill, MD, MHS
personKOL score —
Lynn Johnson, Pharm D
personKOL score —